Pull to refresh
Logo
Daily Brief
Following
Why Ranks Sign Up
Herbert Kim Lyerly

Herbert Kim Lyerly

George Barth Geller Distinguished Professor of Immunology, Duke University

Appears in 1 story

Notable Quotes

"The basic premise is that the immune checkpoint inhibitors work fantastic if the body has already triggered an immune response, but they don't work well in the absence of that. Our vaccine initiates the anti-tumor response, and in combination with the checkpoint inhibitors, works beautifully."

Stories

Therapeutic cancer vaccines emerge from decades of development

New Capabilities

Leading ongoing HER2 vaccine clinical trials

Metastatic breast cancer typically kills most patients within five years. A small group of women vaccinated in a Duke University clinical trial two decades ago have defied that prognosis entirelyโ€”all remain alive today. Researchers discovered these survivors still carry specialized immune cells capable of recognizing their cancer, pointing to a mechanism that could make therapeutic cancer vaccines work reliably.

Updated Jan 31